Unknown

Dataset Information

0

Suppression of GPR56 expression by pyrrole-imidazole polyamide represents a novel therapeutic drug for AML with high EVI1 expression.


ABSTRACT: G protein-coupled receptor 56 (GPR56) is highly expressed in acute myeloid leukemia (AML) cells with high EVI1 expression (EVI1high AML). Because GPR56 is a transcriptional target of EVI1 and silencing of GPR56 expression induces apoptosis, we developed a novel drug to suppress GPR56 expression in EVI1high AML cells. For this purpose, we generated pyrrole-imidazole (PI) polyamides specific to GPR56 (PIP/56-1 or PIP/56-2) as nuclease-resistant novel compounds that interfere with the binding of EVI1 to the GPR56 promoter in a sequence-specific manner. Treatment of EVI1high AML cell lines (UCSD/AML1 and Kasumi-3) with PIP/56-1 or PIP/56-2 effectively suppressed GPR56 expression by inhibiting binding of EVI1 to its promoter, leading to suppression of cell growth with increased rates of apoptosis. Moreover, intravenous administration of PIP/56-1 into immunodeficient Balb/c-RJ mice subcutaneously transplanted with UCSD/AML1 cells significantly inhibited tumor growth and extended survival. Furthermore, organ infiltration by leukemia cells in immunodeficient Balb/c-RJ mice, which were intravenously transplanted using UCSD/AML1 cells, was successfully inhibited by PIP/56-1 treatment with no apparent effects on murine hematopoietic cells. In addition, PIP treatment did not inhibit colony formation of human CD34+ progenitor cells. Thus, PI polyamide targeting of GPR56 using our compound is promising, useful, and safe for the treatment of EVI1high AML.

SUBMITTER: Saha HR 

PROVIDER: S-EPMC6137133 | biostudies-literature | 2018 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Suppression of GPR56 expression by pyrrole-imidazole polyamide represents a novel therapeutic drug for AML with high EVI1 expression.

Saha Hasi Rani HR   Kaneda-Nakashima Kazuko K   Shimosaki Shunsuke S   Suekane Akira A   Sarkar Bidhan B   Saito Yusuke Y   Ogoh Honami H   Nakahata Shingo S   Inoue Kentaro K   Watanabe Takayoshi T   Nagase Hiroki H   Morishita Kazuhiro K  

Scientific reports 20180913 1


G protein-coupled receptor 56 (GPR56) is highly expressed in acute myeloid leukemia (AML) cells with high EVI1 expression (EVI1<sup>high</sup> AML). Because GPR56 is a transcriptional target of EVI1 and silencing of GPR56 expression induces apoptosis, we developed a novel drug to suppress GPR56 expression in EVI1<sup>high</sup> AML cells. For this purpose, we generated pyrrole-imidazole (PI) polyamides specific to GPR56 (PIP/56-1 or PIP/56-2) as nuclease-resistant novel compounds that interfere  ...[more]

Similar Datasets

| S-EPMC3619939 | biostudies-literature
| S-ECPF-GEOD-59502 | biostudies-other
2013-01-31 | E-GEOD-43253 | biostudies-arrayexpress
2014-07-28 | E-GEOD-59502 | biostudies-arrayexpress
| S-EPMC3562772 | biostudies-literature
2013-01-31 | GSE43253 | GEO
2014-07-28 | GSE59502 | GEO
| S-EPMC3375050 | biostudies-literature
| S-EPMC3479560 | biostudies-literature
| S-EPMC4933941 | biostudies-literature